用于治疗干眼疾病的氨改性纳米纤维
Fang Wu1, Zeen Lv1, Yingzheng Mao1
1Eye Center, The Second Affiliated Hospital, School of Medicine, Zhejiang University, Zhejiang Provincial Key Laboratory of Ophthalmology, Zhejiang Provincial Clinical Research Center for Eye Diseases, Zhejiang Provincial Engineering Institute on Eye Diseases, Hangzhou 310009, China.
Journal of colloid and interface science
|December 29, 2024
概括
新的氨酸改性氧化纳米颗粒 (HA-CeO2) 为治疗干眼疾病 (DED) 提供了双重方法. 这种创新的治疗方法可以清除活性氧物种 (ROS) 并稳定膜,解决关键的DED机制.
科学领域:
- 生物材料科学 生物材料科学
- 纳米技术纳米技术
- 眼科医生 眼科 眼科
背景情况:
- 干眼病 (DED) 影响全球近一半的人口,造成严重的健康和经济负担.
- 目前的治疗方法,如人工眼,需要频繁的管理,并没有解决反应性氧物种 (ROS) 刺激.
- 炎症和氧化应激是DED的关键病理机制.
研究的目的:
- 开发氨酸 (HA) 修饰的氧化 (CeO2) 纳米颗粒 (HA-CeO2) 用于同时清理ROS和增强DED中的膜稳定性.
- 在体外和DED小鼠模型中研究HA-CeO2的抗氧化和抗炎作用.
主要方法:
- 合成和HA-CeO2纳米粒子的表征.
- 在体外评估ROS清除活性和下调炎症因子 (MMP9,IL-1β).
- 在DED小鼠模型中评估HA-CeO2的疗效和安全性.
主要成果:
- HA-CeO2纳米颗粒有效地清除了ROS,并减少了炎症因子表达.
- 在体内研究证实了HA-CeO2在DED小鼠模型中的抗氧化和抗炎作用.
- HA-CeO2 显示出良好的生物相容性和安全性.
结论:
- HA-CeO2纳米粒子通过同时针对氧化应激和炎症,代表了对DED的有希望的治疗策略.
- 这种基于纳米酶的方法为治疗与炎症和氧化压力相关的疾病提供了新的见解.
- HA-CeO2有可能改善撕裂膜的稳定性,并减少DED的负担.
相关概念视频
Open Angle Glaucoma: Treatment
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Drugs such as carbonic anhydrase inhibitors, α2- and...
Angle Closure Glaucoma: Treatment
Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
Ophthalmic Drug Delivery Systems
Ophthalmic drug delivery faces major limitations due to poor absorption across the corneal membrane. This process is primarily driven by diffusion and is influenced by two main factors: the physicochemical properties of the drug and tear drainage. Most ophthalmic drugs, such as pilocarpine, epinephrine, atropine, and local anesthetics, are weak bases. They are typically formulated at an acidic pH to enhance chemical stability. However, this leads to high ionization, reducing their ability to...


